Sean Ainsworth is of Ocuphire Pharma, Inc.. Currently has a direct ownership of 88,358 shares of OCUP, which is worth approximately $86,590. The most recent transaction as insider was on Jun 11, 2024, when has been sold 41,143 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.4K
0% 3M change
87.14% 12M change
Total Value Held $86,590

Sean Ainsworth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
41,143 Added 31.77%
88,358 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
10,976 Added 18.86%
47,215 Common Stock
Oct 19 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
-
1,574 Added 3.68%
41,239 Common Stock
Nov 19 2020
BUY
Open market or private purchase
-
8,865 Added 16.56%
44,665 Common Stock
Nov 05 2020
BUY
Grant, award, or other acquisition
-
35,800 Added 50.0%
35,800 Common Stock
SA

Sean Ainsworth

Farmington Hills, MI

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP